glucose, (beta-d)-isomer has been researched along with probucol in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dinerstein, RJ; Doherty, NS; Jackson, RL; Ku, G; Schmidt, LF | 1 |
| Doherty, NS; Jackson, RL; Ku, G; Wolos, JA | 1 |
2 other study(ies) available for glucose, (beta-d)-isomer and probucol
| Article | Year |
|---|---|
Ex vivo lipopolysaccharide-induced interleukin-1 secretion from murine peritoneal macrophages inhibited by probucol, a hypocholesterolemic agent with antioxidant properties.
Topics: Administration, Oral; Animals; Antioxidants; Arthritis, Experimental; Cholesterol; Interleukin-1; Interleukin-2; Interleukin-3; Lipopolysaccharides; Macrophages; Mice; Mice, Inbred Strains; Peritoneal Cavity; Phenols; Probucol; Rats; Rats, Inbred Lew; Secretory Rate; Triglycerides; Tumor Necrosis Factor-alpha; Zinc; Zymosan | 1990 |
Inhibition by probucol of interleukin 1 secretion and its implication in atherosclerosis.
Topics: Animals; Arteriosclerosis; In Vitro Techniques; Interleukin-1; Lipopolysaccharides; Lipoproteins, LDL; Macrophages; Mice; Phenols; Probucol; Time Factors; Zinc; Zymosan | 1988 |